'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Bajaj Healthcare Limited
BAJAJHCARE (NSE) · BAJAJHCARE (BSE 539872) · ISIN INE411U01027 · Pharmaceuticals · Est. 1993 · listed 2021 · website
Not on any surveillance list
In Q2 FY27 (quarter to 30 September 2026, standalone), revenue was ₹175.9 cr and profit after tax ₹14.09 cr. Revenue was 18.9% higher than in Q2 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 standalone | ₹175.9 cr | ₹14.09 cr | 4.18 | 17 Oct 2026 |
| Q1 FY27 standalone | ₹165.63 cr | ₹13.7 cr | 4.06 | 20 Jul 2026 |
| Q4 FY26 standalone | ₹153.06 cr | −₹22.85 cr | −7.15 | 8 May 2026 |
| Q3 FY26 standalone | ₹161.22 cr | ₹15.67 cr | 4.87 | 16 Jan 2026 |
| Q2 FY26 standalone | ₹147.91 cr | ₹11.11 cr | 3.47 | 17 Oct 2025 |
| Q1 FY26 standalone | ₹148.84 cr | ₹11.83 cr | 3.64 | 28 Jul 2025 |
| Q4 FY25 standalone | ₹154.47 cr | ₹11.18 cr | 3.46 | 27 May 2025 |
| Q3 FY25 standalone | ₹388.13 cr | ₹28.32 cr | 9.72 | 12 Feb 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹557.16 cr | ₹267.52 cr | ₹981.15 cr |
| 31 Mar 2026 standalone | ₹533 cr | ₹233.46 cr | ₹923.22 cr |
| 30 Sep 2025 standalone | ₹486.39 cr | ₹221.23 cr | ₹838.87 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 58.59% | 2.09% | 1.96% | 41.41% |
Latest filings
- Bajaj Healthcare Limited has informed the Exchange about Link of Recording 19 October 2026 · NSE
- Bajaj Healthcare Limited has informed the Exchange regarding a press release dated October 17, 2026, titled "Press Release on the financial results of the Company for the quarter ended September 30, 2 17 October 2026 · NSE
- Bajaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 17 October 2026 · NSE
- Annual Report FY2025-26 (New) 29 August 2026 · NSE
- Bajaj Healthcare Limited has informed the Exchange about Transcript 27 July 2026 · NSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Aurobindo Pharma Limited
- Divi's Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 19 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.